Once-Weekly Diabetes Treatment Gets FDA OK - MedPage Today


MyFox Chicago
Once-Weekly Diabetes Treatment Gets FDA OK
MedPage Today
By Crystal Phend, Senior Staff Writer, MedPage Today WASHINGTON -- The delay is over for diabetes drug Bydureon (exenatide extended-release), with FDA approval making it the first once-weekly treatment for type 2 disease.
Diabetes Drug Injected Weekly Wins FDA ApprovalNew York Times
Amylin, Alkermes Diabetes Drug Wins Approval on Third TryBusinessWeek
Amylin's long-delayed diabetes drug gets FDA nodUSA TODAY

all 190 news articles »

continue reading

Market Wire - Cardiologist Recommends Innovative Diet for Heart Healthy Living in New Book

January 26, 2012 --

A new book challenges popular conceptions about healthy eating and nutrition for adults suffering from diabetes and heart disease. After more...

continue reading